Moderna and Merck are seeking approval for intismeran autogene, a melanoma vaccine, after their November 6 earnings release, boosting shares up 700%.







FDA approves Voceryq, the first DNA-based immunotherapy for HPV-driven recurrent respiratory papillomatosis (RRP), offering hope for patients avoiding repeated










Moderna and Merck are seeking approval for intismeran autogene, a melanoma vaccine, after their November 6 earnings release,…

Trump pressures Europe to cut drug prices, while his administration delays new launches, as a March 2026 poll…

FDA approves Voceryq, the first DNA-based immunotherapy for HPV-driven recurrent respiratory papillomatosis (RRP), offering hope for patients avoiding…

Generic manufacturers may shift focus to reliability due to supply chain issues and price pressure affecting the industry.

Fresenius expands biosimilars portfolio through big deal with WuXi Biologics, gaining option rights on up to 37 candidates.

Germany's AfD softens anti euro stance ahead of national government hopes. Explore the party's strategic shift and political…

Trump veto looms as Democrats win Congress, sparking fresh trade hurdles, oversight hearings and plans to roll back…

France deploys 70,000 police to contain nationwide protests over living costs and government policies, following recent riots and…

Diplomats face deep rifts over wars and trade at the G20 meeting in Atlanta, with Secretary of State…

Patients struggle to find accepting doctors nationwide, facing repeated rejections despite Medicare coverage and family recommendations.